CD47 and neoplasm: In the treatment groups, rat anti-mouse CD47 antibody generated from MIAP301 hybridoma cells (16 mg/kg), ET (30 mg/kg), or combination, was administrated via i.p. every other day for 14 days (total seven treatments) till Day 38 and tumor imaging and animal survival were monitored.